A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study

References

• GaoYGuanWXuGSleep disturbances and health-related quality of life in adults with steady-state bronchiectasisPLoS One201497e10297025036723
   PubMed Web of Science ®Google Scholar
• McNicholasWTImpact of sleep in COPDChest20001172 Suppl48S53S10673475
   PubMed Web of Science ®Google Scholar
• McNicholasWTVerbraeckenJMarinJMSleep disorders in COPD: the forgotten dimensionEur Respir Rev20132212936537523997063
   PubMedGoogle Scholar
• CormickWOlsonLGHensleyMJSaundersNANocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung diseaseThorax198641118468543824271
   PubMed Web of Science ®Google Scholar
• AgustiAHednerJMarinJMBarbéFCazzolaMRennardSNighttime symptoms: a forgotten dimension of COPDEur Respir Rev20112012118319421881146
   PubMedGoogle Scholar
• StephensonJJCaiQMocarskiMTanHDoshiJASullivanSDImpact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis20151057758625844033
   PubMed Web of Science ®Google Scholar
• PokrzywinskiRFMeadsDMMcKennaSPGlendenningGARevickiDADevelopment and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS)Health Qual Life Outcomes200979819968881
   PubMed Web of Science ®Google Scholar
• ZeidlerMRMartinJLKleerupECSPIROMICS Research GroupSleep disruption as a predictor of quality of life among patients in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS)Sleep201841518
   Web of Science ®Google Scholar
• MarroneOSalvaggioAInsalacoGRespiratory disorders during sleep in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis20061436337218044093
   PubMedGoogle Scholar
• LacasseYSérièsFVujovic-ZotovicNEvaluating nocturnal oxygen desaturation in COPD-revisedRespir Med201110591331133721561753
   PubMed Web of Science ®Google Scholar
• GayPCChronic obstructive pulmonary disease and sleepRespir Care2004491395114733621
   PubMedGoogle Scholar
• HudgelDWDevadattaPDecrease in functional residual capacity during sleep in normal humansJ Appl Physiol Respir Environ Exerc Physiol1984575131913226520027
   PubMed Web of Science ®Google Scholar
• HudgelDWMartinRJCapehartMJohnsonBHillPContribution of hypoventilation to sleep oxygen desaturation in chronic obstructive pulmonary diseaseJ Appl Physiol Respir Environ Exerc Physiol19835536696776629905
   PubMed Web of Science ®Google Scholar
• BlockAJBoysenPGWynneJWThe origins of cor pulmonale; a hypothesisChest1979752109110421540
   PubMed Web of Science ®Google Scholar
• FlenleyDCClinical hypoxia: causes, consequences, and correctionLancet19781806354254676082
   PubMed Web of Science ®Google Scholar
• LacasseYBernardSSérièsFInternational Nocturnal Oxygen (INOX) Research GroupMulti-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trialBMC Pulm Med2017171828069009
   PubMed Web of Science ®Google Scholar
• SergiMRizziMAndreoliAPecisMBruschiCFanfullaFAre COPD patients with nocturnal REM sleep-related desaturations more prone to developing chronic respiratory failure requiring long-term oxygen therapy?Respiration200269211712211961424
   PubMed Web of Science ®Google Scholar
• McNicholasWTCalverleyPMLeeAEdwardsJCTiotropium Sleep Study in COPD InvestigatorsLong-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPDEur Respir J200423682583115218993
   PubMed Web of Science ®Google Scholar
• RyanSDohertyLSRockCNolanGMMcNicholasWTEffects of salmeterol on sleeping oxygen saturation in chronic obstructive pulmonary diseaseRespiration201079647548119684384
   PubMed Web of Science ®Google Scholar
• BatemanEDFergusonGTBarnesNDual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE studyEur Respir J20134261484149423722616
   PubMed Web of Science ®Google Scholar
• WedzichaJADecramerMFickerJHAnalysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group studyLancet Respir Med20131319920924429126
   PubMed Web of Science ®Google Scholar
• VogelmeierCFBatemanEDPallanteJAlagappanVKD’AndreaPChenHBanerjiDEfficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group studyLancet Respir Med201311516024321804
   PubMed Web of Science ®Google Scholar
• WedzichaJABanerjiDChapmanKRFLAME InvestigatorsIndacaterol-glycopyrronium versus salmeterol-fluticasone for COPDN Engl J Med2016374232222223427181606
   PubMed Web of Science ®Google Scholar
• HaysRDStewartASleep measuresStewartALWareJEMeasuring Function and Well-Being The Medical Outcomes Study ApproachDurham, NCDuke University Press1992235259
   Google Scholar
• JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• MacintyreNCrapoROViegiGStandardisation of the single-breath determination of carbon monoxide uptake in the lungEur Respir J200526472073516204605
   PubMed Web of Science ®Google Scholar
• WangerJClausenJLCoatesAStandardisation of the measurement of lung volumesEur Respir J200526351152216135736
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationAmerican Psychiatric Association, Diagnostic and Statistical Manual of Mental DisordersWashington, DCAmerican Psychiatric Association1994
   Google Scholar
• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2018 Report)2018 Available from: www.goldcopd.orgAccessed December 11, 2018
   Google Scholar